Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users

开发可摄入生物传感器以增强药物使用者的 PrEP 依从性

基本信息

  • 批准号:
    10674107
  • 负责人:
  • 金额:
    $ 6.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The HIV epidemic continues to disproportionately affect individuals with health disparities. Marginalization, substance use disorder, stigma and other health disparities contribute to decreased mood which influences key health behaviors like adherence to oral HIV pre-exposure chemoprophylaxis (PrEP). These key disparities contributed to the world failing to achieve the UNAIDS 90-90-90 goals in 2020 to end the HIV epidemic. One of the pillars to ending the epidemic is improving uptake and persistent to PrEP. While efficacious, men who have sex with men (MSM) with substance use disorders (SUD) experience multiple intersectional marginalized identities which lead to PrEP nonadherence. Technologies to detect PrEP adherence patterns continue to be developed to advance interventions that support adherence. The parent award, K23DA044874, develops a preventive intervention, PrEPSteps, that leverages an ingestible radiofrequency transmitter (digital pill system) to directly measure adherence. This digital pill then drives personalized adherence skills training that addresses PrEP nonadherence at the moment it occurs. In this administrative supplement, we will integrate measures of health disparities including the intersectional discrimination index and profile of mood states into the fabric of the parent pilot randomized controlled trial to understand mechanisms of how these health disparities influence uptake of the digital pill intervention and PrEP adherence. We will additionally conduct formative qualitative interviews among parent study participants and healthcare providers who prescribed PrEP grounded in the Consolidated Framework for Implementation Research (CFIR) to understand how health systems may implement digital pills to measure PrEP adherence with a lens of health disparities.
摘要 艾滋病毒流行病继续对健康状况不平等的个人产生不成比例的影响。边缘化, 物质使用障碍,耻辱和其他健康差异有助于降低情绪,影响关键 健康行为,如坚持口服艾滋病毒暴露前化学预防(PrEP)。这些关键的差异 导致世界未能实现联合国艾滋病规划署在2020年结束艾滋病毒流行的90-90-90目标。之一 结束这一流行病的支柱是提高对PrEP的吸收和坚持。虽然有效, 患有物质使用障碍(SUD)的男男性行为者(MSM)经历了多个交叉边缘化 导致PrEP不依从的身份。检测PrEP依从性模式的技术仍然是 制定了促进支持依从性的干预措施。母公司奖K23 DA 044874开发了一种 预防性干预,PrEPSteps,利用可摄入的射频发射器(数字药丸系统) 来直接测量依从性。这种数字药丸然后驱动个性化的坚持技能培训, 解决PrEP不依从的问题。在这份行政补充中,我们将整合 健康差异的措施,包括交叉歧视指数和情绪状态的概况, 父母试点随机对照试验的结构,以了解这些健康的机制, 差异影响数字药丸干预和PrEP依从性的摄取。我们还将进行 父母研究参与者和开PrEP处方的医疗保健提供者之间的形成性定性访谈 基于实施研究综合框架(CFIR),以了解健康 系统可以实现数字药丸以测量具有健康差异的透镜的PrEP依从性。

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Wastewater network infrastructure in public health: Applications and learnings from the COVID-19 pandemic.
  • DOI:
    10.1371/journal.pgph.0000061
  • 发表时间:
    2021-01-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sharara, Nour;Endo, Noriko;Erickson, Timothy B
  • 通讯作者:
    Erickson, Timothy B
Digital Biomarker Applications Across the Spectrum of Opioid Use Disorder.
  • DOI:
    10.1080/28324765.2023.2240375
  • 发表时间:
    2023-08
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Rigatti;Brittany P. Chapman;P. Chai;D. Smelson;K. Babu;Stephanie P Carreiro
  • 通讯作者:
    M. Rigatti;Brittany P. Chapman;P. Chai;D. Smelson;K. Babu;Stephanie P Carreiro
Novichok agents: a historical, current, and toxicological perspective.
  • DOI:
    10.1080/24734306.2018.1475151
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Chai PR;Hayes BD;Erickson TB;Boyer EW
  • 通讯作者:
    Boyer EW
In Reply to "Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?"
回复“羟氯喹过量:地西泮和钾输注的确切作用是什么?”
An Internet of Things Buttons to Measure and Respond to Restroom Cleanliness in a Hospital Setting: Descriptive Study.
用于测量和响应医院环境中卫生间清洁度的物联网按钮:描述性研究。
  • DOI:
    10.2196/13588
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    7.4
  • 作者:
    Chai,PeterR;Zhang,Haipeng;Jambaulikar,GuruprasadD;Boyer,EdwardW;Shrestha,Labina;Kitmitto,Loay;Wickner,PaigeG;Salmasian,Hojjat;Landman,AdamB
  • 通讯作者:
    Landman,AdamB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter R Chai其他文献

Advising Around Cannabis for Sleep: Clearing Up the Smoke
关于大麻睡眠的建议:清除烟雾

Peter R Chai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter R Chai', 18)}}的其他基金

Ketamine for the treatment for opioid use disorder and suicidal ideation in the emergency department
氯胺酮用于治疗急诊科阿片类药物使用障碍和自杀意念
  • 批准号:
    10646993
  • 财政年份:
    2023
  • 资助金额:
    $ 6.75万
  • 项目类别:
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities
一种新型机器人废水分析系统,用于量化住宅社区中阿片类药物的暴露和处理
  • 批准号:
    10549579
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项双盲、安慰剂对照随机临床试验
  • 批准号:
    10593244
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
Smart Steps: A context-aware adherence intervention to improve PrEP adherence among men who have sex with men (MSM) with substance use disorder
明智的步骤:情境感知的依从性干预措施可提高患有物质使用障碍的男男性行为者 (MSM) 的 PrEP 依从性
  • 批准号:
    10468388
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
Ketamine for the treatment for alcohol use disorder in the emergency department: A pilot double-blind, placebo-controlled randomized clinical trial
氯胺酮在急诊科治疗酒精使用障碍:一项试点双盲、安慰剂对照随机临床试验
  • 批准号:
    10703512
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities
一种新型机器人废水分析系统,用于量化住宅社区中阿片类药物的暴露和处理
  • 批准号:
    10313450
  • 财政年份:
    2020
  • 资助金额:
    $ 6.75万
  • 项目类别:
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities
一种新型机器人废水分析系统,用于量化住宅社区中阿片类药物的暴露和处理
  • 批准号:
    10328984
  • 财政年份:
    2020
  • 资助金额:
    $ 6.75万
  • 项目类别:
A novel robotic wastewater analysis system to quantify opioid exposure and treatment in residential communities
一种新型机器人废水分析系统,用于量化住宅社区中阿片类药物的暴露和处理
  • 批准号:
    10381304
  • 财政年份:
    2020
  • 资助金额:
    $ 6.75万
  • 项目类别:
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users
开发可摄入生物传感器以增强药物使用者的 PrEP 依从性
  • 批准号:
    10401432
  • 财政年份:
    2018
  • 资助金额:
    $ 6.75万
  • 项目类别:
Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users
开发可摄入生物传感器以增强药物使用者的 PrEP 依从性
  • 批准号:
    9924467
  • 财政年份:
    2018
  • 资助金额:
    $ 6.75万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 6.75万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 6.75万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 6.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 6.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 6.75万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 6.75万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 6.75万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 6.75万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 6.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了